Technology
Health
Medical

Nymox Pharmaceuticals

$2.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (2.68%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NYMX and other stocks, options, ETFs, and crypto commission-free!

About

Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. Read More It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Employees
2
Headquarters
Nassau, New Providence
Founded
1995
Market Cap
139.46M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
112.46K
High Today
$2.30
Low Today
$2.19
Open Price
$2.21
Volume
34.18K
52 Week High
$4.60
52 Week Low
$1.25

Collections

Technology
Health
Medical
Pharmaceutical
Biopharmaceutical
Research And Development
Cancer Prevention
North America (Non-US/Canada)

Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 28, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.